Here are brokerage firms’ trading strategies Dr Reddy’s LabsCredit Suisse downgrades it to underperform from neutral as sharp erosion in the US business leads to high EPS cut. It has also slashed FY17/18 EPS by 35/19 percent and target to Rs 2750 per share. Near-term outlook weak with further hit from expiry of McNeil contract. Jeferries downgraded to underperform with target of Rs 2850 per share. It expects earnings to remain flat over FY16-18.Bank of America Merrill Lynch cuts EPS and target price but reiterates buy call. Maruti Deutsche Bank retains hold rating. It has raised EPS forecasts by 8-10 percent & target price by 5 percent to Rs 4100 per share. It says margin could be affected by yen appreciation & elevated discountsGoldman Sachs reiterates buy stating it has edge over competition is rising led by better product execution. It has increased FY17/18 EPS estimates by 8 percent/4 percent and target to Rs 4923 from Rs 4750 per share.Ambuja Cements CLSA maintain buy call with a target of Rs 310 per share. It has raised EPS estimates by 3-5 percent. Religare has a buy call on with target increased to Rs 290 from Rs 270 per share. Zee Entertainment Enterprises Macquarie maintains outperform with revised target of Rs 540 per share. Citi maintains sell call with target increased to Rs 410 from Rs 395 per share as ad growth is likely to be slower than before. Bank of America Merrill lynch reiterates buy call with target increased by 12 percent to Rs 520 per share. It has increased FY17/18/19 EBITDA estimates by 3.2 percent/3.1 percent/ 3.1 percent.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
